Cancer Immunosurveillance: NKG2D Breaks Cover
Overview
Authors
Affiliations
The idea of cancer immunosurveillance has regained interest in recent years. In this issue of Immunity, Guerra et al. (2008) present the first genetic evidence for surveillance of primary tumors by a natural killer cell-associated receptor.
Guo D, Jin C, Gao Y, Lin H, Zhang L, Zhou Y Cell Biosci. 2023; 13(1):51.
PMID: 36895027 PMC: 9999509. DOI: 10.1186/s13578-023-01005-7.
KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer.
Zhang Y, Chen Z, Jiang A, Gao G Sci Rep. 2022; 12(1):1976.
PMID: 35132098 PMC: 8821622. DOI: 10.1038/s41598-022-05997-z.
Gullickson G, Ambrose E, Hoover R, Kornbluth J Int J Immunol Immunother. 2020; 3(1).
PMID: 32083188 PMC: 7032549. DOI: 10.23937/2378-3672/1410018.
The Role of Tumor-Derived Vesicles in the Regulation of Antitumor Immunity.
Ukrainskaya V, Rubtsov Y, Knorre V, Maschan M, Gabibov A, Stepanov A Acta Naturae. 2020; 11(4):33-41.
PMID: 31993233 PMC: 6977957. DOI: 10.32607/20758251-2019-11-4-33-41.
Bassani B, Baci D, Gallazzi M, Poggi A, Bruno A, Mortara L Cancers (Basel). 2019; 11(4).
PMID: 30939820 PMC: 6521276. DOI: 10.3390/cancers11040461.